Chandra Bhagat Pharma

56.00
0.00
(0.00%)
Market Cap
42.30 Cr
EPS
2.03
PE Ratio
49.12
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
113.75
52 Week Low
46.15
PB Ratio
1.41
Debt to Equity
0.63
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,674.60
#1 4,01,792.60
35.03
#1 49,887.20
12.06
#1 9,648
-18.99
41.82
6,539.00
1,73,589.90
79.22
8,184.00
0.89
1,600
23.05
59.58
1,470.20
1,18,735.50
22.51
26,520.70
14.17
4,155
30.28
45.47
3,127.80
1,05,859.00
54.96
10,785.70
11.59
1,656
10.91
39.95
1,247.70
1,04,115.00
#1 18.43
28,905.40
12.36
5,578
21.14
65.56
2,414.30
99,608.80
50.15
10,615.60
19.57
1,942
-10.91
42.84
928.00
93,378.50
20.02
19,831.50
13.82
3,831
-0.19
62.05
1,961.10
89,532.20
27.27
20,141.50
#1 19.94
1,936
#1 112.49
43.58
1,136.80
66,025.50
19.10
29,559.20
17.55
3,169
-0.50
41.29
30,605.00
65,033.50
46.07
6,097.20
10.80
1,201
27.83
52.43
Forecast
Actual
Growth Rate
Revenue Growth
93.92 %
Net Income Growth
66.67 %
Cash Flow Change
17.49 %
ROE
60.49 %
ROCE
19.18 %
EBITDA Margin (Avg.)
-38.87 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
TTM
Revenue
107
94
71
96
120
233
0
Expenses
102
91
67
91
116
228
0
EBITDA
5
4
4
4
4
4
0
Operating Profit %
4 %
3 %
5 %
3 %
3 %
-3 %
0 %
Depreciation
0
0
0
0
0
1
0
Interest
4
3
4
3
2
1
0
Profit Before Tax
1
0
0
1
1
2
0
Tax
0
0
0
0
0
1
0
Net Profit
1
0
0
1
1
2
0
EPS in ₹
13.38
0.55
0.25
1.06
1.20
2.03
0.00

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
83
75
72
73
61
102
Fixed Assets
1
0
0
1
1
3
Current Assets
81
73
70
71
58
98
Capital Work in Progress
0
0
0
0
0
0
Investments
4
1
0
0
0
0
Other Assets
78
74
71
72
60
99
Total Liabilities
83
75
72
73
61
102
Current Liabilities
53
34
33
38
27
71
Non Current Liabilities
16
15
13
8
6
2
Total Equity
14
26
26
27
28
29
Reserve & Surplus
14
18
18
19
20
22
Share Capital
1
8
8
8
8
8

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
-1
0
-0
-0
2
3
1
-2
Investing Activities
0
0
0
-0
-0
0
0
0
-0
-2
Operating Activities
0
0
-9
-6
4
-7
8
12
5
6
Financing Activities
0
0
8
7
-4
7
-6
-10
-4
-6

Share Holding

% Holding
Mar 2021
Sept 2021
Mar 2022
Sept 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Promoter
71.80 %
71.80 %
70.11 %
69.09 %
68.24 %
68.69 %
68.77 %
69.29 %
71.20 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.33 %
1.33 %
0.48 %
0.61 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.89 %
0.89 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
18.85 %
15.24 %
17.79 %
18.97 %
18.98 %
17.07 %
16.92 %
12.84 %
11.16 %
Others
9.36 %
12.96 %
12.10 %
11.94 %
12.78 %
12.02 %
12.09 %
17.39 %
17.03 %
No of Share Holders
106
90
126
126
146
134
152
315
316

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 55.00 56.16
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 70.00 71.49
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 73.21 72.25

Announcements

Appointment Of Secretarial Auditor.4 days ago
Result For The Financial Year March 31 2025.4 days ago
Board Meeting Outcome for Outcome Of Board Meeting4 days ago
Board Meeting Intimation for Approval Of Audited Financial Statement As On March 31 2025.9 days ago
General-UpdatesApr 21, 2025
Closure of Trading WindowMar 31, 2025
Non-Applicability Of Compliance Governance Report.Jan 21, 2025
Result For The Half Year Ended As On September 30, 2024.Nov 13, 2024
Board Meeting Outcome for Outcome Of Board Meeting Be Held On November 13, 2024.Nov 13, 2024
Board Meeting Intimation for Approval Of Unaudited Result For The Half Year Ended As On September 30, 2024Nov 07, 2024
Voting ResultOct 02, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 02, 2024
Closure of Trading WindowOct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2024
Reg. 34 (1) Annual Report.Sep 07, 2024
Book Closure And Record Date For The Purpose Of Annual General Meeting.Sep 07, 2024
Notice Of Annual General Meeting Scheduled To Be Held On September 30, 2024Sep 07, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On September 07, 2024 For The Approval Of Notice Of AGM Along With Other Businesses.Sep 07, 2024
Non-Applicability Of CGR Report Certificate.Jul 19, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Jul 18, 2024
Declaration Of Unmodified Opinion.May 30, 2024
Result As On March 31, 2024May 30, 2024
Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2024
Board Meeting Intimation for Approval Of Audited Financial Result As On March 31, 2024.May 23, 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2024
Compliance Certificate Under Regulation 7(3) For Period Ended March 31, 2024.Apr 29, 2024
Compliance Certificate Under Regulation 40(10).Apr 29, 2024
Closure of Trading WindowApr 01, 2024
Financial Result As On 30.09.2023.Nov 09, 2023
Board Meeting Outcome for Results For The Half Year Ended 30Th September, 2023.Nov 09, 2023
Board Meeting Intimation for Approval Of Un-Audited Financial Result For Half Year Ended 30Th September, 2023.Nov 02, 2023
Closure of Trading WindowOct 01, 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 30, 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 30, 2023
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2023
Reg. 34 (1) Annual Report.Sep 05, 2023
Record Date And Book Closure Dates For Annual General Meeting.Sep 05, 2023
Notice Of Annual General Meeting.Sep 05, 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th September, 2023.Sep 05, 2023
Audited Financial Result Of The Company For The Period Ended 31St March, 2023.May 22, 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On 22Nd May, 2023 For Approval Of Audited Financial Result Of The Company For The Period Ended 31St March, 2023.May 22, 2023
Board Meeting Intimation for Approval Of Audited Financial Result For The Half Year And Year Ended 3St March, 2023 And Any Other Business.May 15, 2023
Compliance Disclosure On Large Corporate.Apr 30, 2023
Compliance Certificate For The Period Ended 31St March, 2023.Apr 29, 2023
Certificate Under Reg 40(10).Apr 29, 2023
Closure of Trading WindowMar 31, 2023
Approval Of Un-Audited Financial Result As On 30Th September, 2022.Nov 14, 2022
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November, 2022 For Approval Of Un-Audited Financial Result As On 30Th September, 2022.Nov 14, 2022
Board Meeting Intimation for Approval Of Un-Audited Financial Result As On 30.09.2022.Nov 07, 2022
Statement Of Investor Complaints For The Quarter Ended September 2022Oct 20, 2022

Technical Indicators

RSI(14)
Neutral
46.44
ATR(14)
Less Volatile
8.92
STOCH(9,6)
Neutral
62.20
STOCH RSI(14)
Overbought
90.29
MACD(12,26)
Bullish
0.25
ADX(14)
Weak Trend
15.86
UO(9)
Bearish
85.39
ROC(12)
Downtrend And Accelerating
-6.62
WillR(14)
Overbought
-6.67